{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiff7gwotrwyofuhtndashcazlqqfxfwydcugtowfl25o3an7s3ham",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlc54z3vij72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigffqlrs67qbr4yvlf4hkcdm2rz37xuotvziaywrx7hp77c5n5bnq"
    },
    "mimeType": "image/jpeg",
    "size": 84009
  },
  "path": "/news/2026-05-mrna-superior-standard-dose-vaccine.html",
  "publishedAt": "2026-05-07T16:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "For adults aged 50 years or older, an investigational messenger RNA (mRNA)-based vaccine (mRNA-1010) is superior to standard-dose licensed vaccines for preventing influenza-like illness, according to a study published in the New England Journal of Medicine.",
  "title": "mRNA-1010 superior to standard-dose vaccine for preventing flu, finds study"
}